Related references
Note: Only part of the references are listed.Inhaled Nitric Oxide in Preterm Infants: A Systematic Review
Pamela K. Donohue et al.
PEDIATRICS (2011)
Apelin Attenuates Hyperoxic Lung and Heart Injury in Neonatal Rats
Yvonne P. de Visser et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Pulmonary hypertension in children: A historical overview Introduction
Steven H. Abman
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Neonatal pulmonary hypertension
Robin H. Steinhorn
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts
Yuan James Rao et al.
ACTA PHARMACOLOGICA SINICA (2009)
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury
J. Cortijo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia
K. Woyda et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Does PDE4 inhibition improve alveolarisation in hyperoxia-exposed immature rodents?
C. Mehats et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats
Mohamed Izikki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Development and Pathology of Pulmonary Hypertension
Rubin M. Tuder et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Drug therapies in bronchopulmonary dysplasia: debunking the myths
Win Tin et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2009)
Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury
Yvonne P. de Visser et al.
RESPIRATORY RESEARCH (2009)
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury
Y. P. de Visser et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice
Lucia De Franceschi et al.
FASEB JOURNAL (2008)
Effects of Phosphodiesterase 4 Inhibition on Alveolarization and Hyperoxia Toxicity in Newborn Rats
Celine Mehats et al.
PLOS ONE (2008)
Current concepts: Chronic lung disease after premature birth
Eugenio Baraldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn
Steven H. Abman
NEONATOLOGY (2007)
Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat
Marleen H. M. Hessel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells
Jennifer Millen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2006)
Phosphodiesterase inhibitors in airways disease
KF Chung
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells
EJ Growcott et al.
RESPIRATORY RESEARCH (2006)
Inhaled lloprost reverses vascular remodeling in chronic experimental pulmonary hypertension
RT Schermuly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats
C Guignabert et al.
CIRCULATION (2005)
Microarray analysis of gene expression profiles of cardiac myocytes and fibroblasts after mechanical stress, ionising or ultraviolet radiation
M Boerma et al.
BMC GENOMICS (2005)
Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease
BJ Lipworth
LANCET (2005)
cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling
PG Phillips et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress
GTA Wagenaar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat
M Yi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats
RT Schermuly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Effects of theophylline on the pattern of spontaneous breathing in preterm infants less than 1000 g of birth weight
M von Poblotzki et al.
EARLY HUMAN DEVELOPMENT (2003)
Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
M Conti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
LH Clapp et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Cyclic nucleotide phosphodiesterases
DM Essayan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)